Parathyroid adenoma localization: surgeon-performed ultrasound versus sestamibi

Laryngoscope. 2006 Aug;116(8):1380-4. doi: 10.1097/01.mlg.0000227957.06529.22.

Abstract

Objectives: Compare surgeon-performed ultrasound versus sestamibi for preoperative parathyroid adenoma localization.

Study design: Single-institutional cohort.

Methods: One hundred six consecutive patients undergoing parathyroidectomy at an academic institution between 2004 to 2005 were included. Of those, 103 underwent both surgeon-performed ultrasound and sestamibi-Tc99m localization preoperatively. Primary outcome is sensitivity for adenoma localization to correct quadrant (right vs. left, superior vs. inferior).

Results: Hypercalcemia resolved in 97% of patients. Sensitivities for correct quadrant localization for ultrasound versus sestamibi were 87% versus 58% (P < .001). Specificities were 95%. Positive and negative predictive values were 85% versus 78% and 96% versus 87%, respectively. Combined sensitivity was 93%. Sensitivities for correct side localization were 91% and 74% (P = .002).

Conclusions: Ultrasound appears more sensitive than sestamibi for localization to correct quadrant or side when performed in-office by the author in this cohort.

Publication types

  • Comparative Study

MeSH terms

  • Adenoma / diagnosis*
  • Adenoma / diagnostic imaging
  • Adenoma / surgery
  • Humans
  • Hypercalcemia / diagnosis
  • Hyperparathyroidism / diagnosis
  • Parathyroid Neoplasms / diagnosis*
  • Parathyroid Neoplasms / diagnostic imaging
  • Parathyroid Neoplasms / surgery
  • Parathyroidectomy
  • Predictive Value of Tests
  • Radionuclide Imaging
  • Sensitivity and Specificity
  • Technetium Tc 99m Sestamibi*
  • Ultrasonography

Substances

  • Technetium Tc 99m Sestamibi